openPR Logo
Press release

Swine Respiratory Disease Treatment Market - Global Industry Insights 2025

02-09-2018 07:13 AM CET | Health & Medicine

Press release from: Pharmaceutical Report By CMI

Swine Respiratory Disease Treatment Market - Global Industry

Swine respiratory disease affects the respiratory tract of swine. It is one of the prevalent cause of death in nursery pigs and grower/finisher pigs. There are multiple pathogens, viruses, and other secondary causative agents that causes respiratory disease in swine. Primary pathogens that causes swine respiratory disease are Actinobacillus pleuropneumoniae (APP), Mycoplasma hyopneumoniae, Bordetella bronchiseptica, and Pasteurella multocida. Viral agents involved are porcine reproductive and respiratory syndrome (PRRS) virus and swine influenza virus (SIV). Various diseases that come under ambit of swine respiratory disease are mycoplasma pneumonia, swine influenza, classical swine fever atrophic rhinitis, pleuropneumonia, porcine reproductive and respiratory syndrome, and porcine circovirus type 2. These infectious agents together increase the severity of the disease.

Access Table of Content (TOC) Of the Report: https://www.coherentmarketinsights.com/ongoing-insight/toc/1274

China, U.S., and E.U to drive growth of the swine respiratory disease treatment market due to high pork production

According to the factsheet by United Nations Food and Agriculture Organization (UN-FAO) worldwide there is close to one billion headcount of swine. China has highest number of headcount, followed by the U.S. and EU. These regions are expected to drive growth of the respiratory disease treatment market, owing to high pork production. As per the United States Department of Agriculture (USDA), around 108.2 million metric tons of pork was produced in 2016, which requires supply of healthy swine. Early vaccination is essential for healthy swine as respiratory disease in swine leads to lung damage, poor growth of swine, medication cost, and in turn results into lower economic efficiency for swine farmer. Therefore many of these regions opt for vaccination to prevent the respiratory disease in swine, which in turn is expected to propel growth for the swine respiratory disease treatment market. According to the study published in Virology Journal in 2017, emergence of porcine cyclovirus type 3 in pigs in regions such as China, U.S. and some part of Europe is fueling growth of the swine respiratory disease treatment market. According to Scientific Reports published in 2013, porcine reproductive and respiratory syndrome is economically most important disease of swine in North America, Europe, and Asia. North America spends around US$ 600 million annually for treatment of this disease.

However, increasing inclination of population towards adoption of vegetarian diet in China leading to lower swine farming prospect is restating growth of the swine respiratory treatment market. Also, according to the United States Department of Agriculture (USDA) cost of pork was dropping till end of 2017, which negatively affects the swine farming.

Swine Respiratory Disease Treatment Market Taxonomy:

On the basis of product type:
-Drugs
-Vaccines

On the basis of indication:
-Mycoplasmal Pneumonia
-Swine Influenza
-Classical Swine Fever
-Porcine Reproductive and Respiratory Syndrome (PRRS)
-Porcine Circovirus-Associated Disease
-Pseudorabies

On the basis of distribution channel:
-Veterinary hospital
-Pharmacies

Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/swine-respiratory-disease-treatment-market-1274

Key players operating in the swine respiratory disease treatment market include Zoetis, Inc. Merck Animal Health, Bayer AG, Boehringer Ingelheim Vetmedica, Inc., Elanco Animal Health, Virbac Group, Norbrook, Ceva Santé Animale, Vetoquinol, Bimeda holdings PLC, and Agrilabs, Inc. In January 2018, FDA approved dose of 100 gram per ton feed for Lincomix (Product from Zoetis, Inc.), which contains lincomycin hydrochloride to reduce the severity of swine respiratory disease from mycoplasma hyopneumoniae. Lincomix is the only feed medication approved against mycoplasma hyopneumoniae, which is leading cause for swine pneumonia. In 2016, Gamithromycin (ZACTRAN) was approved for use in pigs by USDA. In June 2017, a team of researchers from University of Leicester isolated 20 bacteriophages that targets 72 potential drug resistant bacteria in pigs. This bacteriophages were found to be more specific for treatment of bacterial infections in pigs. MSD Animal Health (known as Merck Animal Health in the U.S. and Canada) in November 2017, signed an agreement to acquire Vilsan Pharmaceuticals which is a division of Vimar Group, based in Turkey. Vilsan Pharmaceuticals holds significant share in animal health products in Turkey.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Swine Respiratory Disease Treatment Market - Global Industry Insights 2025 here

News-ID: 937707 • Views: 199

More Releases from Pharmaceutical Report By CMI

Rising prevalence of diabetes is a major factor driving growth of the diabetic f …
Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the
Glucagon-Like Peptide-1 (Glp-1) Analogs Market Global Industry Insights, Trends, …
Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level. GLP-1 analogs prevents the breakdown of GLP-1, thereby enhancing the glucose depended insulin release, suppresses the glucagon release (which reduces hepatic glucose output), and reduces gastric emptying rate (resulting in weight loss from reduced appetite). GLP-1 analogs do not cause hypoglycemia like other class of anti-diabetic
Multiple Sclerosis Therapeutics Market to Surpass US$ 24.4 Billion by 2025
Increasing prevalence of multiple sclerosis to augment market growth Multiple sclerosis is a widespread disabling neurological condition, mostly diagnosed in people in the age group 20–50 years. According to the Multiple Sclerosis Foundation, 2017, this autoimmune condition affects 2.5 million people with the global incidence of around 7 cases per 100,000 people per year. The study also states that prevalence rates varies between ethnic and geographical latitudes, ranging from 50 to
Diabetic Foot Ulcers Treatment Market to Surpass US$ 9.49 Billion Threshold by 2 …
Diabetic foot ulcers is a common condition in diabetic patients. It is a disabling disorder, which might lead to amputation of the leg. Mortality due to diabetic foot ulcers is high and chances of recurrence of cured foot ulcers is also high and this in turn leads to increasing demand for proper treatment of diabetic foot ulcers. Diabetic foot ulcer is caused due to neuropathic and vascular changes in the

All 5 Releases


More Releases for Swine

Swine Vaccines Industry Forecast to 2018-2023
Swine Vaccines report focuses on the Swine Vaccines in United States market, to split the market based on manufacturers, states, type and application. United States Swine Vaccines Industry provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Swine Vaccines Market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. The report provides key statistics
Swine Influenza Market Research Study for Forecast Period 2017 - 2025
Swine influenza, also known as swine flu, is a highly contagious respiratory disease caused by Type-A influenza viruses that infect the respiratory tracts of pigs. Swine influenza viruses are mostly found in pigs. However, occasionally, they have also been found to be spread among humans who have direct contact with infected pigs. The swine influenza disease spreads in humans usually through two routes: pig-to-human transmission and human-to-human transmission. Pig-to-human transmission
Swine Diseases Treatment Market to Remain Lucrative During 2017 - 2025
Swine diseases treatments help in improving health, increase production of livestock and prevent transmission of diseases among animals in a cost effective manner. Swine diseases treatments is the most lucrative product segment of focus for veterinary drug manufacturers. Growing awareness on animal health with early disease detection and preventive medicines will be responsible for rapid growth of swine diseases treatment market. The increasing prevalence of diseases such as swine influenza
Swine Influenza Vaccines Sales Market Report : 2017
Reports And Markets Publish a New Market Research Report On –"Swine Influenza Vaccines Sales Market Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/global-swine-influenza-vaccines-sales-market-report-2017-1541103 In this report, the global Swine Influenza Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several
Swine Feed Market - Global Industry Analysis 2024
Global Swine Feed: Market Overview Feed additives play a vital role in improving the nutrition provided to animals – they primarily enhance the feed and food quality. Swine feed, in particular, delivers nutrition to swine in the course of rearing them. Feed extracts are an important source of nutrition given that they make the feed more digestible. Among the key feed essences that are contained in the diet of pigs are:
Global Swine Feed Industry 2016, Trends,Opportunities and Growth Drivers
"The Report Global Swine Feed Industry 2016, Trends and Forecast Report provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Description 2016 Global Swine Feed Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Swine Feed industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan